229 related articles for article (PubMed ID: 26512949)
1. Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.
Nalla AK; Williams TF; Collins CP; Rae DT; Trobridge GD
Mol Carcinog; 2016 Nov; 55(11):1761-1771. PubMed ID: 26512949
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis Screens for Prostate Cancer Using Replication-Incompetent Lentiviral Vectors.
Trobridge GD
Methods Mol Biol; 2019; 1907():103-114. PubMed ID: 30542994
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to identify driver genes involved in androgen-independent prostate cancer.
Schinke EN; Bii V; Nalla A; Rae DT; Tedrick L; Meadows GG; Trobridge GD
Mol Cancer; 2014 May; 13():120. PubMed ID: 24885513
[TBL] [Abstract][Full Text] [Related]
4. Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes.
Bii VM; Collins CP; Hocum JD; Trobridge GD
Oncotarget; 2018 Mar; 9(21):15451-15463. PubMed ID: 29643985
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer.
Lin YW; Wen YC; Chu CY; Tung MC; Yang YC; Hua KT; Pan KF; Hsiao M; Lee WJ; Chien MH
Cell Death Dis; 2020 Jul; 11(7):591. PubMed ID: 32719332
[TBL] [Abstract][Full Text] [Related]
8. [Screening of membrane antigen differentially expressed in androgen-dependent prostate cancer and androgen-independent prostate cancer].
Zhang X; Tang Z; Qi L; Chen H; Luo Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):817-23. PubMed ID: 22954909
[TBL] [Abstract][Full Text] [Related]
9. Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter.
Yu D; Jia WW; Gleave ME; Nelson CC; Rennie PS
Prostate; 2004 Jun; 59(4):370-82. PubMed ID: 15065085
[TBL] [Abstract][Full Text] [Related]
10. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation.
Nadiminty N; Chun JY; Lou W; Lin X; Gao AC
Prostate; 2008 Dec; 68(16):1725-33. PubMed ID: 18781579
[TBL] [Abstract][Full Text] [Related]
12. Prolonging androgen sensitivity in prostate cancer - a role for COX inhibitors?
Richards A; McGeechan K; Niknam M; Salomon R; Kurek C; Dong Q; Patel MI
ANZ J Surg; 2009 Sep; 79(9):641-7. PubMed ID: 19895521
[TBL] [Abstract][Full Text] [Related]
13. Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts.
Kim K; Watson PA; Lebdai S; Jebiwott S; Somma AJ; La Rosa S; Mehta D; Murray KS; Lilja H; Ulmert D; Monette S; Scherz A; Coleman JA
Clin Cancer Res; 2018 May; 24(10):2408-2416. PubMed ID: 29463549
[No Abstract] [Full Text] [Related]
14. Veratramine Inhibits the Cell Cycle Progression, Migration, and Invasion via ATM/ATR Pathway in Androgen-Independent Prostate Cancer.
Kim HY; Lee SW; Choi SK; Ashim J; Kim W; Beak SM; Park JK; Han JE; Cho GJ; Ryoo ZY; Jeong J; Lee YH; Jeong H; Yu W; Park S
Am J Chin Med; 2023; 51(5):1309-1333. PubMed ID: 37385965
[TBL] [Abstract][Full Text] [Related]
15. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
[TBL] [Abstract][Full Text] [Related]
16. Progression to androgen-independent LNCaP human prostate tumors: cellular and molecular alterations.
Zhou JR; Yu L; Zerbini LF; Libermann TA; Blackburn GL
Int J Cancer; 2004 Jul; 110(6):800-6. PubMed ID: 15170660
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.
Amler LC; Agus DB; LeDuc C; Sapinoso ML; Fox WD; Kern S; Lee D; Wang V; Leysens M; Higgins B; Martin J; Gerald W; Dracopoli N; Cordon-Cardo C; Scher HI; Hampton GM
Cancer Res; 2000 Nov; 60(21):6134-41. PubMed ID: 11085537
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
Ettinger SL; Sobel R; Whitmore TG; Akbari M; Bradley DR; Gleave ME; Nelson CC
Cancer Res; 2004 Mar; 64(6):2212-21. PubMed ID: 15026365
[TBL] [Abstract][Full Text] [Related]
20. Independence of HIF1a and androgen signaling pathways in prostate cancer.
Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
